Nome del prodotto |
K-strofantina miscela variabile |
Sinonimi |
k-Strophanthoside; NSC 7530; STROFANTOSIDE-K; Strofantidina cimarosio beta-glucosio alfa-glucosio; Strofantidina cimarosio beta-glucosio alfa-glucosio [tedesco]; k-Strofantozyd; k-Strofantozyd [polacco]; k-Strofantidina-gamma; k-Strophantosid; k-Strophantosid [tedesco]; k-Strophantoside; (3beta,5beta)-3-((O-beta-D-glucopiranosil-(1,6)-O-beta-D-glucopiranosil-(1,4)-2,6-dideossi-3-O-metil-beta-D-ribo-esopiranosil)-5,14-diidrossi-19-ossocard-20(22)-enolide; 5-beta-Card-20(22)-enolide, 3-beta-((O-beta-D-glucopiranosil-(1-6)-O-beta-D-glucopiranosil-(1-4)-2,6-dideossi-3-O-metil-beta-D-ribo-esopiranosil)ossi)-5,14-diidrossi-19-osso-; Card-20(22)-enolide, 3-((O-beta-D-glucopiranosil-(1-6)-O-beta-D-glucopiranosil-(1-4)-2,6-dideossi-3-O-metil-beta-D-ribo-hexopiranosil)ossi)-5,14-diidrossi-19-osso-, (3beta,5beta)- (9CI); 3-{[esopiranosil-(1->6)esopiranosil-(1->4)-2,6-dideossi-3-O-metilesopiranosil]ossi}-5,14-diidrossi-19-ossocard-20(22)-enolide; (3beta,5beta,17xi)-3-{[beta-D-glucopiranosil-(1->6)-beta-D-glucopiranosil-(1->4)-2,6-dideossi-3-O-metil-beta-D-ribo-esopiranosil]ossi}-5,14-diidrossi-19-ossocard-20(22)-enolide |
Nome inglese |
K-strophanthin variable mixture;k-Strophanthoside; NSC 7530; STROPHANTHOSIDE-K; Strophanthidin + cymarose + beta-glucose + alpha-glucose; Strophanthidin + cymarose + beta-glucose + alpha-glucose [German]; k-Strofantozyd; k-Strofantozyd [Polish]; k-Strophanthidin-gamma; k-Strophantosid; k-Strophantosid [German]; k-Strophantoside; (3beta,5beta)-3-((O-beta-D-glucopyranosyl-(1.6)-O-beta-D-glucopyranosyl-(1.4)-2,6-dideoxy-3-O-methyl-beta-D-ribo-hexopyranosyl)oxy)-5,14-dihydroxy-19-oxocard-20(22)-enolide; 5-beta-Card-20(22)-enolide, 3-beta-((O-beta-D-glucopyranosyl-(1-6)-O-beta-D-glucopyranosyl-(1-4)-2,6-dideoxy-3-O-methyl-beta-D-ribo-hexopyranosyl)oxy)-5,14-dihydroxy-19-oxo-; Card-20(22)-enolide, 3-((O-beta-D-glucopyranosyl-(1-6)-O-beta-D-glucopyranosyl-(1-4)-2,6-dideoxy-3-O-methyl-beta-D-ribo-hexopyranosyl)oxy)-5,14-dihydroxy-19-oxo-, (3beta,5beta)- (9CI); 3-{[hexopyranosyl-(1->6)hexopyranosyl-(1->4)-2,6-dideoxy-3-O-methylhexopyranosyl]oxy}-5,14-dihydroxy-19-oxocard-20(22)-enolide; (3beta,5beta,17xi)-3-{[beta-D-glucopyranosyl-(1->6)-beta-D-glucopyranosyl-(1->4)-2,6-dideoxy-3-O-methyl-beta-D-ribo-hexopyranosyl]oxy}-5,14-dihydroxy-19-oxocard-20(22)-enolide |
Formula molecolare |
C42H64O19 |
Peso Molecolare |
872.9462 |
InChI |
InChI=1/C42H64O19/c1-19-36(61-38-35(51)33(49)31(47)27(60-38)17-56-37-34(50)32(48)30(46)26(15-43)59-37)25(54-3)13-29(57-19)58-21-4-9-40(18-44)23-5-8-39(2)22(20-12-28(45)55-16-20)7-11-42(39,53)24(23)6-10-41(40,52)14-21/h12,18-19,21-27,29-38,43,46-53H,4-11,13-17H2,1-3H3/t19-,21+,22?,23+,24-,25+,26-,27-,29+,30-,31-,32+,33+,34-,35-,36-,37-,38+,39-,40+,41+,42+/m1/s1 |
Numero CAS |
33279-57-1 |
EINECS |
251-439-1 |
Struttura molecolare |
|
Densità |
1.49g/cm3 |
Punto di ebollizione |
1027.2°C at 760 mmHg |
Indice di rifrazione |
1.631 |
Punto d'infiammabilità |
304°C |
Pressione di vapore |
0mmHg at 25°C |
Simboli di pericolo |
|
Codici di Rischio |
|
Sicurezza Descrizione |
|
|